Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Jun;3(6):489-499.
doi: 10.1016/j.oret.2019.02.002. Epub 2019 Mar 11.

Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants

Affiliations
Comparative Study

Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants

Stephen P Yoon et al. Ophthalmol Retina. 2019 Jun.

Abstract

Purpose: Evaluate and compare the retinal microvasculature in the superficial capillary plexus (SCP) in Alzheimer's disease (AD), mild cognitive impairment (MCI), and cognitively intact controls using OCT angiography. OCT parameters were also compared.

Design: Cross-sectional study.

Participants: Seventy eyes from 39 AD participants, 72 eyes from 37 MCI participants, and 254 eyes from 133 control participants were enrolled.

Methods: Participants were imaged using Zeiss Cirrus HD-5000 with AngioPlex (Carl Zeiss Meditec, Dublin, CA) and underwent cognitive evaluation with Mini-Mental State Examination.

Main outcome measures: Vessel density (VD) and perfusion density (PD) in the SCP within the Early Treatment Diabetic Retinopathy Study 6-mm circle, 3-mm circle, and 3-mm ring were compared between groups. Foveal avascular zone (FAZ) area, central subfield thickness (CST), macular ganglion cell-inner plexiform layer (GC-IPL) thickness, and peripapillary retinal nerve fiber layer (RNFL) thickness were also compared.

Results: Alzheimer's participants showed significantly decreased SCP VD and PD in the 3-mm ring (P = 0.001 and P = 0.002, respectively) and 3-mm circle (P = 0.003 and P = 0.004, respectively) and decreased SCP VD in the 6-mm circle (P = 0.047) compared with MCI and significantly decreased SCP VD and PD in the 3-mm ring (P = 0.008 and P = 0.004, respectively) and 3-mm circle (P = 0.015 and P = 0.009, respectively) and SCP PD in the 6-mm circle (P = 0.033) when compared with cognitively intact controls. There was no difference in SCP VD or PD between MCI and controls (P > 0.05). FAZ area and CST did not differ significantly between groups (P > 0.05). Alzheimer's participants showed significantly decreased GC-IPL thickness over the inferior (P = 0.032) and inferonasal (P = 0.025) sectors compared with MCI and significantly decreased GC-IPL thickness over the entire (P = 0.012), superonasal (P = 0.041), inferior (P = 0.004), and inferonasal (P = 0.006) sectors compared to controls. MCI participants showed significantly decreased temporal RNFL thickness (P = 0.04) compared with controls.

Conclusions: Alzheimer's participants showed significantly reduced macular VD, PD, and GC-IPL thickness compared with MCI and controls. Changes in the retinal microvasculature may mirror small vessel cerebrovascular changes in AD.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No conflicting relationship exists for any author.

Figures

Figure 1.
Figure 1.
Early Treatment Diabetic Retinopathy Study (ETDRS) grid regions used for (A) 3mm circle, (B) 3mm ring, and (C) 6mm circle regions. Vessel density and perfusion density were averaged over the highlighted blue area for each respective region.
Figure 2.
Figure 2.
Representative optical coherence tomography angiography 3×3mm images of the superficial capillary plexus (SCP) of the left eye from a community control subject (A), mild cognitive impairment (MCI) subject (B), and Alzheimer’s disease (AD) subject (C). Corresponding quantitative color maps (Carl Zeiss Meditec, Dublin, CA) of vessel density (D-F) and perfusion density (G-I) of the SCP, with the scale on the right, show decreased vessel density and perfusion density in the subject with AD (F, I) compared to the control subject (D, G) and MCI subject (E, H).
Figure 3.
Figure 3.
Representative optical coherence tomography angiography 6×6mm images of the superficial capillary plexus (SCP) of the left eye from a community control subject (A), mild cognitive impairment (MCI) subject (B), and Alzheimer’s disease (AD) subject (C). Corresponding quantitative color maps (Carl Zeiss Meditec, Dublin, CA) of vessel density (D-F) and perfusion density (G-I) of the SCP, with the scale on the right, show decreased vessel density and perfusion density in the subject with AD (F, I) compared to the control subject (D, G) and MCI subject (E, H).
Figure 4.
Figure 4.
Ganglion cell analysis (Carl Zeiss Meditec, Dublin, CA) of representative optical coherence tomography images of the macula of the left eye in a control subject (A), MCI subject (B), and AD subject (C). Corresponding GC-IPL thickness for each elliptical annular region shows diffuse thinning in the AD subject (F) compared to the control (D) and MCI subjects (E). S, superior; ST, supero-temporal; SN, supero-nasal; I, inferior; IT, infero-temporal; IN, inferonasal.

References

    1. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (20102050) estimated using the 2010 census. Neurology 2013;80:1778–1783. - PMC - PubMed
    1. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000;123:484–498. - PubMed
    1. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262–1270. - PubMed
    1. Ward A, Tardiff S, Dye C, Arrighi HM. Rate of conversion from prodromal Alzheimer’s disease to Alzheimer’s dementia: a systematic review of the literature. Dement Geriatr Cogn Dis Extra 2013;3:320–332. - PMC - PubMed
    1. Grossman I, Lutz MW, Crenshaw DG, et al. Alzheimer’s disease: diagnostics, prognostics and the road to prevention. EPMA J 2010;1:293–303. - PMC - PubMed

Publication types

MeSH terms